Laurent Knoops

5.0k total citations · 1 hit paper
53 papers, 3.4k citations indexed

About

Laurent Knoops is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Laurent Knoops has authored 53 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 18 papers in Hematology and 12 papers in Oncology. Recurrent topics in Laurent Knoops's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Lymphoma Diagnosis and Treatment (9 papers). Laurent Knoops is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Lymphoma Diagnosis and Treatment (9 papers). Laurent Knoops collaborates with scholars based in Belgium, France and Italy. Laurent Knoops's co-authors include Jean‐Jacques Kiladjian, Tiziano Barbui, Heinz Gisslinger, Francisco Cervantes, Claire Harrison, Alessandro M. Vannucchi, Giovanni Barosi, Deborah Hunter, Haifa Kathrin Al‐Ali and Viktoriya Stalbovskaya and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Laurent Knoops

51 papers receiving 3.3k citations

Hit Papers

JAK Inhibition with Ruxolitinib versus Best Available The... 2012 2026 2016 2021 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
    2012 1.2k citations Claire Harrison, Jean‐Jacques Kiladjian et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Knoops Belgium 26 1.9k 1.6k 1.4k 638 625 53 3.4k
Prithviraj Bose United States 32 1.9k 1.0× 1.9k 1.2× 2.2k 1.5× 709 1.1× 634 1.0× 277 4.0k
Matthias Mayerhofer Austria 32 820 0.4× 1.3k 0.8× 1.1k 0.8× 446 0.7× 814 1.3× 75 3.2k
Ramón V. Tiu United States 40 2.0k 1.1× 2.2k 1.4× 3.5k 2.4× 550 0.9× 389 0.6× 159 5.0k
Daniela Cilloni Italy 33 1.6k 0.9× 1.6k 1.0× 2.7k 1.9× 848 1.3× 676 1.1× 181 4.4k
H. Kantarjian United States 29 2.1k 1.1× 995 0.6× 2.4k 1.7× 637 1.0× 776 1.2× 120 3.9k
Kazimierz Kuliczkowski Poland 29 1.1k 0.6× 1.1k 0.7× 1.2k 0.9× 1.2k 2.0× 184 0.3× 202 3.5k
Nicoletta Testoni Italy 35 1.9k 1.0× 1.5k 1.0× 3.7k 2.6× 744 1.2× 1.0k 1.6× 187 4.4k
Stefan Faderl United States 26 1.7k 0.9× 1.2k 0.7× 2.0k 1.4× 548 0.9× 279 0.4× 115 3.6k
Gerald M. Segal United States 13 1.4k 0.7× 953 0.6× 2.5k 1.8× 628 1.0× 846 1.4× 20 3.9k
Ilaria Iacobucci Italy 33 1.5k 0.8× 1.1k 0.7× 2.4k 1.7× 587 0.9× 798 1.3× 165 3.7k

Countries citing papers authored by Laurent Knoops

Since Specialization
Citations

This map shows the geographic impact of Laurent Knoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Knoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Knoops more than expected).

Fields of papers citing papers by Laurent Knoops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Knoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Knoops. The network helps show where Laurent Knoops may publish in the future.

Co-authorship network of co-authors of Laurent Knoops

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Knoops. A scholar is included among the top collaborators of Laurent Knoops based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Knoops. Laurent Knoops is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Neste, Éric Van Den, Marc André, Thomas Gastinne, et al.. (2018). A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma. Haematologica. 103(5). 840–848. 42 indexed citations
3.
Devos, Timothy, Yves Béguin, Lucien Noens, et al.. (2017). Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey. European Journal Of Haematology. 100(4). 361–366. 4 indexed citations
4.
Saussoy, Pascale, et al.. (2016). Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases. Cellular and Molecular Life Sciences. 73(24). 4739–4748. 9 indexed citations
5.
Hornakova, Tekla, Sandrine Degryse, Olga Gielen, et al.. (2015). Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities. Journal of Biological Chemistry. 290(48). 29022–29034. 37 indexed citations
6.
7.
Renzis, Benoît De, Véronique Mansat‐De Mas, Eric Wattel, et al.. (2013). Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study. Leukemia Research Reports. 2(2). 64–66. 7 indexed citations
8.
9.
Harrison, Claire, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, et al.. (2012). JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis. New England Journal of Medicine. 366(9). 787–798. 1218 indexed citations breakdown →
10.
Laudadio, Ilaria, Isabelle Manfroid, Younès Achouri, et al.. (2011). A Feedback Loop Between the Liver-Enriched Transcription Factor Network and Mir-122 Controls Hepatocyte Differentiation. Gastroenterology. 142(1). 119–129. 151 indexed citations
11.
Lefebvre, Chantal, et al.. (2010). Multiple myeloma‐associated polyarteritis nodosa. British Journal of Haematology. 149(5). 634–634. 2 indexed citations
12.
Beck, Raphaël, Rozangela Curi Pedrosa, Nicolas Dejeans, et al.. (2010). Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study. Investigational New Drugs. 29(5). 891–900. 56 indexed citations
13.
Hornakova, Tekla, Judith Staerk, Yohan Royer, et al.. (2009). Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers. Journal of Biological Chemistry. 284(11). 6773–6781. 54 indexed citations
14.
Stockis, Julie, Violaine François, Thierry Connerotte, et al.. (2009). Comparison of stable human Treg and Th clones by transcriptional profiling. European Journal of Immunology. 39(3). 869–882. 59 indexed citations
15.
Hornakova, Tekla, Yohan Royer, Laurent Knoops, et al.. (2008). Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the γ Chain. Journal of Biological Chemistry. 283(48). 33569–33577. 23 indexed citations
16.
Knoops, Laurent & Daphne de Jong. (2008). The role of the p53 pathway in the treatment of follicular lymphoma. Cell Cycle. 7(4). 436–439. 7 indexed citations
17.
Glas, Annuska M., Laurent Knoops, Leonie Delahaye, et al.. (2007). Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma. Journal of Clinical Oncology. 25(4). 390–398. 197 indexed citations
18.
Vertommen, Didier, Matthieu Depuydt, Jonathan L. Pan, et al.. (2007). The disulphide isomerase DsbC cooperates with the oxidase DsbA in a DsbD‐independent manner. Molecular Microbiology. 67(2). 336–349. 69 indexed citations
19.
Knoops, Laurent, et al.. (2005). Bortezomib‐induced Sweet syndrome. British Journal of Haematology. 131(2). 142–142. 28 indexed citations
20.
Knoops, Laurent, Jamila Louahed, & Jean‐Christophe Renauld. (2004). IL-9-Induced Expansion of B-1b Cells Restores Numbers but Not Function of B-1 Lymphocytes in xid Mice. The Journal of Immunology. 172(10). 6101–6106. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prithviraj Bose Breakdown of academic impact, for papers by Matthias Mayerhofer Breakdown of academic impact, for papers by Ramón V. Tiu Breakdown of academic impact, for papers by Daniela Cilloni Breakdown of academic impact, for papers by H. Kantarjian Breakdown of academic impact, for papers by Kazimierz Kuliczkowski Breakdown of academic impact, for papers by Nicoletta Testoni Breakdown of academic impact, for papers by Stefan Faderl Breakdown of academic impact, for papers by Gerald M. Segal Breakdown of academic impact, for papers by Ilaria Iacobucci
Rankless by CCL
2026